XML 45 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Cash flows from operating activities    
Net loss $ (3,579) $ (24,148)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 81,627 76,606
Provision for doubtful accounts and sales returns 4,815 4,374
Stock-based compensation expense 95,668 83,659
Deferred taxes (31,163) (21,672)
Amortization of deferred financing costs and discount 1,388 1,827
Other non-cash adjustments 5,106 5,677
Changes in operating assets and liabilities, net of acquisition and disposal of businesses:    
Accounts receivable (4,757) 9,998
Prepaid expenses and other assets 14,488 22,246
Trade accounts payable (3,362) 14,435
Accrued expenses and other liabilities 9,073 (7,028)
Deferred revenue 33,679 23,832
Net cash provided by operating activities 202,983 189,806
Cash flows from investing activities    
Purchase of property and equipment (4,243) (10,512)
Capitalized software and content development costs (44,664) (42,757)
Purchase of net assets of acquired companies, net of cash and restricted cash acquired (13) (20,945)
Cash received in sale of business 0 6,426
Other investing activities (250) 0
Net cash used in investing activities (49,170) (67,788)
Cash flows from financing activities    
Proceeds from issuance of debt 175,800 126,900
Payments on debt (293,957) (229,442)
Stock issuance costs 0 (1,205)
Employee taxes paid for withheld shares upon equity award settlement (35,568) (36,057)
Change in due to customers (339,735) (243,109)
Change in customer funds receivable (3,286) (1,291)
Net cash used in financing activities (496,746) (384,204)
Effect of exchange rate on cash, cash equivalents and restricted cash (311) (14,235)
Net decrease in cash, cash equivalents and restricted cash (343,244) (276,421)
Cash, cash equivalents and restricted cash, beginning of period 733,931 651,762
Cash, cash equivalents and restricted cash, end of period 390,687 $ 375,341
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 31,091  
Total restricted cash 359,596  
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 390,687